Chapman Peter Hume 4
4 · IonQ, Inc. · Filed Jun 18, 2025
Insider Transaction Report
Form 4
IonQ, Inc.IONQ
Chapman Peter Hume
DirectorExecutive Chair
Transactions
- Exercise/Conversion
Common Stock
2025-06-17$0.13/sh+910,740$121,493→ 1,301,069 total - Exercise/Conversion
Common Stock
2025-06-16$0.13/sh+3,581,193$477,731→ 3,971,522 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-06-17$0.13/sh−910,740$121,493→ 1,604,972 totalExercise: $0.14Exp: 2029-05-16→ Common Stock (8,096,905 underlying) - Sale
Common Stock
2025-06-16$38.13/sh−3,581,193$136,536,564→ 390,329 total - Sale
Common Stock
2025-06-17$37.78/sh−910,740$34,406,573→ 390,329 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-06-16$0.13/sh−3,581,193$477,731→ 2,515,712 totalExercise: $0.14Exp: 2029-05-16→ Common Stock (8,096,905 underlying)
Footnotes (4)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.0450 to $39.1450, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.87 to $38.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]All of the shares subject to this option are fully vested and exercisable as of the date hereof